| ALLEN INSTITUTE |
Level III |
5 | 5 |
$109,983 |
| Fred Hutchinson Cancer Center |
Level III |
5 | 5 |
$77,976 |
| Howard Hughes Medical Institute |
Level II |
4 | 4 |
$83,961 |
| SEATTLE CHILDREN'S HOSPITAL |
Level III |
4 | 4 |
$79,449 |
| Fred Hutchinson Cancer Center |
Level II |
3 | 3 |
$89,915 |
| Institute for Systems Biology |
Level IV |
3 | 3 |
$90,000 |
| Fred Hutchinson Cancer Center |
Level IV |
2 | 2 |
$134,523 |
| Institute for Systems Biology |
Level III |
2 | 2 |
$76,058 |
| Maxvax Biotechnology Limited Liability Company |
Level III |
2 | 2 |
$114,400 |
| P4Bios Corporation |
Level II |
2 | 2 |
$98,680 |
| Phenome Health |
Level III |
2 | 2 |
$85,000 |
| Plant Health Care, Inc. |
Level II |
2 | 2 |
$113,000 |
| SEATTLE CHILDREN'S HOSPITAL |
Level II |
2 | 2 |
$79,529 |
| SEATTLE CHILDREN'S HOSPITAL |
Level IV |
2 | 2 |
$107,432 |
| SystImmune, Inc. |
Level III |
2 | 2 |
$130,000 |
| ALLEN INSTITUTE |
Level II |
1 | 1 |
$65,500 |
| ALLEN INSTITUTE |
Level IV |
1 | 1 |
$86,150 |
| Altius Institute for Biomedical Sciences |
Level II |
1 | 1 |
$79,810 |
| AMPEL LLC |
Level II |
1 | 1 |
$101,192 |
| Bristol-Myers Squibb Company |
Level III |
1 | 1 |
$138,000 |
| BYTEDANCE INC. |
Level II |
1 | 1 |
$340,000 |
| BYTEDANCE INC. |
Level IV |
1 | 1 |
$340,000 |
| Chondrex, Inc. |
Level II |
1 | 1 |
$105,040 |
| Dendreon Pharmaceuticals LLC |
Level I |
1 | 1 |
$116,357 |
| Fred Hutchinson Cancer Center |
Level I |
1 | 1 |
$80,172 |
| GenScript USA Inc. |
Level II |
1 | 1 |
$110,450 |
| Howard Hughes Medical Institute |
Level III |
1 | 1 |
$88,691 |
| Institute for Systems Biology |
Level I |
1 | 1 |
$80,169 |
| J. Craig Venter Institute, Inc. |
Level II |
1 | 1 |
$70,000 |
| Johns Hopkins University |
Level II |
1 | 1 |
$88,965 |
| Laboratory Corporation of America |
Level II |
1 | 1 |
$87,235 |
| Neumarker Inc. |
Level I |
1 | 1 |
$180,000 |
| Parse Biosciences, Inc. |
Level I |
1 | 1 |
$80,000 |
| Phenome Health |
Level II |
1 | 1 |
$104,000 |
| Roche Sequencing Solutions, Inc. |
Level III |
1 | 1 |
$139,651 |
| SEATTLE CHILDREN'S HOSPITAL |
Level I |
1 | 1 |
$56,202 |
| Trillium Agriculture, Incorporated |
Level II |
1 | 1 |
$90,000 |
| Universal Cells, Inc. |
Level IV |
1 | 1 |
$153,594 |
| University of Washington |
Level I |
1 | 1 |
$84,072 |
| University of Washington |
Level II |
1 | 1 |
$85,656 |
| Zoetis, Inc. |
Level III |
1 | 1 |
$120,000 |
| Outpace Bio, Inc. |
Level IV |
1 | 1 |
$124,405 |
| SEATTLE CHILDREN'S HOSPITAL |
Level IV |
1 | 1 |
$101,733 |
| SEATTLE CHILDREN'S HOSPITAL |
Level II |
1 | 1 |
$51,542 |
| SEATTLE CHILDREN'S HOSPITAL |
Level III |
1 | 1 |
$74,205 |
| University of Washington |
not stated |
11 | 11 |
$82,008 |